Afuco™ Anti-Human SIGLEC15 ADCC Recombinant Antibody (AB-25E9), ADCC Enhanced (CAT#: AFC-546CL)

Anti-SIGLEC15 ADCC Enhanced Antibody (AB-25E9) is an ADCC enhanced antibody produced by our Afuco™ platform. AB-25E9 is a humanized IgG2 that inhibits the function of Siglec-15 and has tremendous potential as a novel antiresorptive for the treatment of patients with acute bone loss.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA

Figure 1 illustrate the inhibition of the differentiation of human osteoclasts upon treatment with increasing concentrations of anti-Siglec-15 IgG2 chimeric monoclonal antibodies 25B8, 25E6, 25E9 or of a control IgG2 antibody. After treatment, the osteoclasts were stained for TRAP expression.

Figure 1 illustrate the inhibition of the differentiation of human osteoclasts upon treatment with increasing concentrations of anti-Siglec-15 IgG2 chimeric monoclonal antibodies 25B8, 25E6, 25E9 or of a control IgG2 antibody. After treatment, the osteoclasts were stained for TRAP expression.

Figure 2 illustrate the inhibition of the differentiation of mouse osteoclasts upon treatment with increasing concentrations of anti-Siglec-15 IgG2 chimeric monoclonal antibodies 25B8, 25E6, 25D8 or of a control IgG2. After treatment, the osteoclasts were stained for TRAP expression.

Figure 2 illustrate the inhibition of the differentiation of mouse osteoclasts upon treatment with increasing concentrations of anti-Siglec-15 IgG2 chimeric monoclonal antibodies 25B8, 25E6, 25D8 or of a control IgG2. After treatment, the osteoclasts were stained for TRAP expression.

Figure 3 illustrate the ability of the 25E9 candidate antibody that is specific for Siglec-15 to inhibit the bone resorbing activity of osteoclasts in comparison with the 25D8 antibody or controls.

Figure 3 illustrate the ability of the 25E9 candidate antibody that is specific for Siglec-15 to inhibit the bone resorbing activity of osteoclasts in comparison with the 25D8 antibody or controls.

A: cells treated with M-CSF; B: cells treated with M-CSF and RANKL; C: cells treated with the 25D8 antibody at 1 mg/ml; D: cells treated with the 25D8 antibody at 10 mg/ml; E: cells treated with control IgG at 1 mg/ml; F: cells treated with control IgG at 10 mg/ml; G: cells treated with the 25E9 antibody at 1 mg/ml; H: cells treated with the 25E9 antibody at 10 mg/ml).


Specifications

  • Host Species
  • Humanized
  • Derivation
  • Humanized
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Osteoporosis

Product Property

  • Purity
  • Purity>95% by SDS-PAGE
  • Storage
  • ≤6 months at 4°C; ≥6 months at -20°C.

Target

  • Alternative Names
  • SIGLEC15; sialic acid binding Ig-like lectin 15; CD33L3; HsT1361; SIGLEC-15; sialic acid-binding Ig-like lectin 15; CD33 antigen-like 3; CD33 molecule-like 3

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "SIGLEC15"

Humanized Antibody

CAT Product Name Application Type
TAB-568CL Human Anti-SIGLEC15 Recombinant Antibody (TAB-568CL) ELISA Human IgG2

Mouse Antibody

CAT Product Name Application Type
MOB-0362MC Rabbit Anti-Human SIGLEC15 Antibody WB, IHC-P, P-ELISA

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-546CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare